Will Inovio Pharmaceuticals Stock See Higher Levels After A 6% Rise In A Week?

Will Inovio Pharmaceuticals Stock See Higher Levels After A 6% Rise In A Week?

The stock price of Inovio Pharmaceutic, a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, reached its 52-week high levels of around $19 in February this year, before a large sell-off resulted in INO stock falling to levels of around $6 in April..